COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
基本信息
- 批准号:7720765
- 负责人:
- 金额:$ 11.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:Affinity ChromatographyApoptoticBacteriaBiologicalBiophysicsCalmodulinCellsCenters of Research ExcellenceComputer Retrieval of Information on Scientific Projects DatabaseCore FacilityCrystallographyCytosineDNMT3B geneData CollectionDifferentiation and GrowthEnsureEnzymesEscherichia coliFibroblastsFundingGene Expression ProfileGlutathione S-TransferaseGoalsGrantHumanInclusion BodiesInsectaInstitutionJurkat CellsLabelLaboratoriesLarge T AntigenLearningLigand BindingManuscriptsMetabolicMetabolic PathwayMetabolismMethodsMethyltransferaseMitochondriaNumbersPeptidesPhenotypePreparationProductionPropertyProteinsPublishingRNA InterferenceRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResourcesSchemeSolutionsSourceStable Isotope LabelingStem cellsStructureTissuesUnited States National Institutes of HealthWorkX ray diffraction analysisX-Ray CrystallographyX-Ray Diffractionbasebronchial epitheliumcancer cellcell typeinterestmetabolomicsprogramsprotein expressionprotein purificationresearch studysphingosine kinase
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Andrew Lane, Core D Director
The primary aims of the core are to provide infrastructure for and support to structural analysis and metabolomics of cancer cells and tissue, and for producing proteins in high yield suitable for NMR analysis. This includes stable isotope labeling strategies including N-15 and C-13 precursors. Our goals continue to be to streamline both data collection and analysis as well as introduce new labeling strategies to provide more detailed information about specific metabolic pathways.
Established researchers and new recruits to the program are seeing the benefits of the core facility for their research. This includes both protein production for biophysical analyses by X-ray crystallography, NMR and Biophysics, as well as extensive use of the metabolomics capabilities of the Core (see below). Efforts are being made to ensure that new recruits are fully cognizant of the core facilities and will be actively encouraged to use the unique capabilities.
Dr. Chi Li (Project 6) will use metabolomics approaches for understanding metabolic consequences of apoptotic proteins on isolated mitochondria.
Dr. Geoffrey Clark (Project 7) is using the Protein Expression core to produce human DNMT3b (DNA (cytosine-5-)-methyltransferase 3 beta) as a GST fusion that will be used for characterization and biological experiments.
Dr. Magda Kucia (Project 10) is working on stem cells for regenerative therapy. In addition to characterizing the gene expression profile of such cells during expansion, she is interested in determining the metabolic phenotype of such cells to learn about the precise requirements for growth and differentiation in terms of energy and anabolic metabolism.
Dr. Hong Ye (COBRE graduate) makes use of the expression core facilities for protein production, advice and analysis and will need the NMR capabilities for some functional analyses of the proteins whose structures she has solved by X-ray diffraction methods.
Dr. Jason Chesney (COBRE graduate) has continued to make extensive use of the facility and has been analyzing the metabolic consequences of expression of iPFK2 and ras (and effects of RNAi knockdowns) as well as the effects of immortalization via hTERT and large T antigen expression in a number of cell types including Jurkat cells, MCF-7, bronchial epithelia and fibroblasts. Metabolite profiles and isotopomer analyses using the NMR facility have been instrumental in discovering consequences of cellular perturbations on the road to transformation (with sometimes surprising results), as well as validating (or otherwise) potential anticancer target enzymes. Some of this work has now been published and other manuscripts are in preparation.
Dr. Binks Wattenberg (COBRE graduate) is expressing sphingosine kinase using transient expression in insect cells and also in bacteria (E. coli). The enzyme in the latter case enters inclusion bodies and has to be refolded after purification. The protein expression laboratory is working on purification schemes based on hexahis affinity chromatography, as well as calmodulin affinity chromatography, which has been shown to separate folded SK from unfolded enzyme. This will be used for biophysical studies, including crystallography, ligand binding, and NMR analyses. In addition, he has been analyzing the solution properties of targeting peptides using the NMR facility.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
安德鲁·莱恩,Core D总监
CORE的主要目标是为癌细胞和组织的结构分析和代谢组学提供基础设施和支持,并生产适合核磁共振分析的高产率蛋白质。这包括稳定的同位素标记战略,包括N-15和C-13前体。我们的目标仍然是简化数据收集和分析,并引入新的标记策略,以提供关于特定代谢途径的更详细信息。
老牌研究人员和该项目的新成员正在看到核心设施为他们的研究带来的好处。这包括用于通过X射线结晶学、核磁共振和生物物理学进行生物物理分析的蛋白质生产,以及广泛使用核心的代谢组学能力(见下文)。正在努力确保新征聘人员充分认识到核心设施,并将积极鼓励他们使用独特的能力。
池莉博士(项目6)将使用代谢组学方法了解凋亡蛋白对分离线粒体的代谢影响。
杰弗里·克拉克博士(项目7)正在利用蛋白质表达核心生产人类Dnmt3b(DNA(胞嘧啶-5-)-甲基转移酶3β)作为GST融合,将用于鉴定和生物学实验。
Magda Kucia博士(项目10)正在研究用于再生治疗的干细胞。除了确定这些细胞在扩增过程中的基因表达谱外,她还对确定这些细胞的代谢表型感兴趣,以了解在能量和合成代谢方面对生长和分化的准确要求。
Hong Ye博士(Cobre毕业生)利用Expression核心设施进行蛋白质生产、建议和分析,并将需要核磁共振功能来对她通过X射线衍射方法解决其结构的蛋白质进行一些功能分析。
Jason Chesney博士(Cobre毕业生)一直在继续广泛使用该设备,并一直在分析iPFK2和ras表达的代谢后果(以及RNAi敲除的影响),以及通过hTERT实现永生化的影响,以及在许多类型的细胞中表达大T抗原的影响,包括Jurkat细胞、MCF-7、支气管上皮和成纤维细胞。利用核磁共振设施进行的代谢物图谱和同位素分析有助于发现细胞扰动在转化过程中的后果(有时会有令人惊讶的结果),以及验证(或其他)潜在的抗癌靶酶。其中一些工作现已出版,其他手稿正在准备中。
Binks Wtenberg博士(Cobre毕业生)正在利用在昆虫细胞和细菌(大肠杆菌)中的瞬时表达来表达鞘氨醇激酶。后一种情况下的酶进入包涵体,必须在纯化后重新折叠。蛋白质表达实验室正在研究基于六丝亲和层析和钙调素亲和层析的纯化方案,这种层析已被证明可以将折叠的SK从未折叠的酶中分离出来。这将用于生物物理研究,包括结晶学、配体结合和核磁共振分析。此外,他一直在使用核磁共振设备分析靶向多肽的溶液性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW N. LANE其他文献
ANDREW N. LANE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW N. LANE', 18)}}的其他基金
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔资源公司:CORE D:NMR
- 批准号:
8360666 - 财政年份:2011
- 资助金额:
$ 11.77万 - 项目类别:
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
- 批准号:
8167778 - 财政年份:2010
- 资助金额:
$ 11.77万 - 项目类别:
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
- 批准号:
7959806 - 财政年份:2009
- 资助金额:
$ 11.77万 - 项目类别:
Stable isotopomer analysis of anabolic metabolic pathways in breast cancer
乳腺癌合成代谢途径的稳定同位素分析
- 批准号:
7876986 - 财政年份:2009
- 资助金额:
$ 11.77万 - 项目类别:
Stable isotopomer analysis of anabolic metabolic pathways in breast cancer
乳腺癌合成代谢途径的稳定同位素分析
- 批准号:
7735895 - 财政年份:2009
- 资助金额:
$ 11.77万 - 项目类别:
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
- 批准号:
7610537 - 财政年份:2007
- 资助金额:
$ 11.77万 - 项目类别:
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
- 批准号:
7382009 - 财政年份:2006
- 资助金额:
$ 11.77万 - 项目类别:
COBRE: LOUISVILLE RES FOUND INC: CORE D: NMR & PROTEIN PURIFICATION FACILITIES
COBRE:路易斯维尔 RES FOUND INC:核心 D:NMR
- 批准号:
7171227 - 财政年份:2005
- 资助金额:
$ 11.77万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 11.77万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 11.77万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 11.77万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 11.77万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10538071 - 财政年份:2022
- 资助金额:
$ 11.77万 - 项目类别:














{{item.name}}会员




